Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS
36
description
Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS. Disclosures. The Good News! We now have simpler and perhaps safer oral anticoagulants. Study Design Phase 2 Clinical Trials of New Anticoagulants Post-ACS. Study Designs Largely similar but a few important differences. - PowerPoint PPT Presentation